|

Liraglutide Pen Injector [Saxenda] Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Saxenda, Victoza

Pipeline

Early 1: 1

Top Sponsors

  • University of Chicago1

Indications

  • Long Covid191
  • Acute Leukemia in Remission1
  • Long COVID1
  • Weight Loss1
  • Multiple Sclerosis1

Chicago, Illinois1 trial

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

University of Chicago Medicine Comprehensive Cancer Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.